APA (7th ed.) Citation

Lin, X., Wei, Y., Li, Y., Xiong, Y., Fang, B., Li, C., . . . Wei, J. (2022). Tormentic Acid Ameliorates Hepatic Fibrosis in vivo by Inhibiting Glycerophospholipids Metabolism and PI3K/Akt/mTOR and NF-κB Pathways. Frontiers in Pharmacology, 13, . https://doi.org/10.3389/fphar.2022.801982

Chicago Style (17th ed.) Citation

Lin, Xing, Yuanyuan Wei, Yan Li, Yuhua Xiong, Bin Fang, Cuiyu Li, Quanfang Huang, Renbin Huang, and Jinbin Wei. "Tormentic Acid Ameliorates Hepatic Fibrosis in Vivo by Inhibiting Glycerophospholipids Metabolism and PI3K/Akt/mTOR and NF-κB Pathways." Frontiers in Pharmacology 13 (2022). https://doi.org/10.3389/fphar.2022.801982.

MLA (9th ed.) Citation

Lin, Xing, et al. "Tormentic Acid Ameliorates Hepatic Fibrosis in Vivo by Inhibiting Glycerophospholipids Metabolism and PI3K/Akt/mTOR and NF-κB Pathways." Frontiers in Pharmacology, vol. 13, 2022, https://doi.org/10.3389/fphar.2022.801982.